{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:14:52Z","timestamp":1793153692103,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Epithelial ovarian cancer is the most frequent gynecologic malignancy; it has a poor prognosis and often occurs bilaterally. Most cases of synchronous bilateral ovarian cancer (SBOC) are metastases from the other ovary, while bilateral primary ovarian cancer is rare.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The patient was a 47-year-old Japanese woman with a complaint of abdominal pain for 1\u00a0month. Imaging results revealed bilateral ovarian tumors with suspicion of malignancy. The patient underwent a laparotomy with total hysterectomy, bilateral salpingo-oophorectomy, partial omentectomy, and resection of suspected dissemination in the peritoneum. Histopathological and immunohistochemical studies showed that the right ovarian tumor was an endometrioid carcinoma (G2) and had no association with endometriotic lesions. However, the left ovarian tumor was a high-grade serous carcinoma (HGSC). The final staging was stage 1 right endometrioid carcinoma and stage IIb left HGSC. Six courses of adjuvant chemotherapy with paclitaxel, docetaxel, and carboplatin were administered. The patient showed no signs of recurrence 24\u00a0months postoperatively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>To the best of our knowledge, the combination of histological types in this case may be the first report of primary bilateral ovarian cancer. In SBOC, it is important to differentiate the subtypes of histology using immunostaining, in addition to morphopathology.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-022-01684-3","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T11:09:36Z","timestamp":1649156976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Synchronous bilateral primary ovarian cancer with right endometroid carcinoma and left high-grade serous carcinoma: a case report and literature review"],"prefix":"10.1186","volume":"22","author":[{"given":"Mimori","family":"Fujimori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0955-4248","authenticated-orcid":false,"given":"Toshifumi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiro","family":"Takanashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Iizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Jimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Soeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiya","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Takeichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"issue":"10177","key":"1684_CR1","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet. 2019;393(10177):1240\u201353.","journal-title":"Lancet"},{"issue":"21","key":"1684_CR2","first-page":"4793","volume":"55","author":"TW Park","year":"1995","unstructured":"Park TW, Felix JC, Wright TC Jr. X chromosome inactivation and microsatellite instability in early and advanced bilateral ovarian carcinomas. Cancer Res. 1995;55(21):4793\u20136.","journal-title":"Cancer Res"},{"key":"1684_CR3","doi-asserted-by":"publisher","first-page":"646340","DOI":"10.1155\/2010\/646340","volume":"2010","author":"F Micci","year":"2010","unstructured":"Micci F, Haugom L, Ahlquist T, Abeler VM, Trope CG, Lothe RA, et al. Tumor spreading to the contralateral ovary in bilateral ovarian carcinoma is a late event in clonal evolution. J Oncol. 2010;2010:646340.","journal-title":"J Oncol"},{"issue":"2","key":"1684_CR4","first-page":"234","volume":"32","author":"MJ Song","year":"2011","unstructured":"Song MJ, Lee CW, Seo KJ, Kim JA, Park JS, Hur SY. A case of bilateral ovarian synchronous tumors (left ovarian serous papillary adenocarcinoma and right ovarian malignant mixed Mullerian tumor). Eur J Gynaecol Oncol. 2011;32(2):234\u20136.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"7","key":"1684_CR5","first-page":"480","volume":"80","author":"F Bernardez Zapata","year":"2012","unstructured":"Bernardez Zapata F, Jauregui Melendrez RA, Cabrera CE. Synchronous double primary ovarian tumor in situ. Ginecol Obstet Mex. 2012;80(7):480\u20136.","journal-title":"Ginecol Obstet Mex"},{"issue":"2","key":"1684_CR6","first-page":"91","volume":"5","author":"SG Khandeparkar","year":"2014","unstructured":"Khandeparkar SG, Deshmukh SD, Lekawale HS, Bhoge A, Ahmed AT. A rare case of synchronous right ovarian clear cell carcinoma and an incidental left ovarian endometrioid carcinoma with immunohistochemical study. J Midlife Health. 2014;5(2):91\u20134.","journal-title":"J Midlife Health"},{"key":"1684_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.5455\/jihp.20130323125431","volume":"2","author":"B Nayal","year":"2014","unstructured":"Nayal B, Mathew M, Rao L, Nagel B, Kumar P. Synchronous bilateral clear cell carcinoma and papillary serous cystadenocarcinoma of the ovaries. J Interdiscip Histopathol. 2014;2:52\u20135.","journal-title":"J Interdiscip Histopathol"},{"issue":"4","key":"1684_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.4103\/0377-4929.142706","volume":"57","author":"A Preeti","year":"2014","unstructured":"Preeti A, Arunachalam KA, Pradeep Y, Mati GM. Bilateral synchronous high-grade serous carcinoma and clear cell carcinoma in right and left ovaries with immunohistochemical confirmation: an exceptional finding. Indian J Pathol Microbiol. 2014;57(4):623\u20135.","journal-title":"Indian J Pathol Microbiol"},{"issue":"2","key":"1684_CR9","first-page":"97","volume":"17","author":"E Gunakan","year":"2018","unstructured":"Gunakan E, Tohma YA, Haberal AN, Ayhan A. Bilateral synchronous ovarian tumours: an uncommon case and review of the literature. Prz Menopauzalny. 2018;17(2):97\u2013100.","journal-title":"Prz Menopauzalny"},{"issue":"27","key":"1684_CR10","doi-asserted-by":"publisher","first-page":"e11330","DOI":"10.1097\/MD.0000000000011330","volume":"97","author":"LJ Zhao","year":"2018","unstructured":"Zhao LJ, Wang P, He Y. Synchronous occurrence of primary right ovarian endometrioid adenocarcinoma and primary left ovarian clear cell adenocarcinoma: a case report. Medicine (Baltimore). 2018;97(27):e11330.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"1684_CR11","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.tjog.2020.03.024","volume":"59","author":"CH Sao","year":"2020","unstructured":"Sao CH, Lai WA, Lin SC, Chang CM, Chen YJ, Wang PH. Endometriosis-associated epithelial ovarian cancer: primary synchronous different cellular type on each ovary. Taiwan J Obstet Gynecol. 2020;59(3):460\u20133.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"23","key":"1684_CR12","doi-asserted-by":"publisher","first-page":"6551","DOI":"10.1158\/0008-5472.CAN-17-1461","volume":"77","author":"X Yin","year":"2017","unstructured":"Yin X, Jing Y, Cai MC, Ma P, Zhang Y, Xu C, et al. Clonality, heterogeneity, and evolution of synchronous bilateral ovarian cancer. Cancer Res. 2017;77(23):6551\u201361.","journal-title":"Cancer Res"},{"issue":"2","key":"1684_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1073\/pnas.1814027116","volume":"116","author":"C Li","year":"2019","unstructured":"Li C, Bonazzoli E, Bellone S, Choi J, Dong W, Menderes G, et al. Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors. Proc Natl Acad Sci U S A. 2019;116(2):619\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1684_CR14","first-page":"857","volume":"12","author":"S Eser","year":"2011","unstructured":"Eser S, Gulhan I, Ozdemir R, Dicle N, Hanhan M, Baloglu A, et al. Synchronous primary cancers of the female reproductive tract in Turkish women. Asian Pac J Cancer Prev. 2011;12(4):857\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"1684_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0028-2243(92)90195-5","volume":"45","author":"A Ayhan","year":"1992","unstructured":"Ayhan A, Yalcin OT, Tuncer ZS, Gurgan T, Kucukali T. Synchronous primary malignancies of the female genital tract. Eur J Obstet Gynecol Reprod Biol. 1992;45(1):63\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"1684_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejogrb.2006.09.010","volume":"136","author":"SY Tong","year":"2008","unstructured":"Tong SY, Lee YS, Park JS, Bae SN, Lee JM, Namkoong SE. Clinical analysis of synchronous primary neoplasms of the female reproductive tract. Eur J Obstet Gynecol Reprod Biol. 2008;136(1):78\u201382.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"1684_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1365-2559.2009.03367.x","volume":"56","author":"N Singh","year":"2010","unstructured":"Singh N. Synchronous tumours of the female genital tract. Histopathology. 2010;56(3):277\u201385.","journal-title":"Histopathology"},{"issue":"3","key":"1684_CR18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ygyno.2019.03.243","volume":"153","author":"H Machida","year":"2019","unstructured":"Machida H, Matsuo K, Yamagami W, Ebina Y, Kobayashi Y, Tabata T, et al. Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: a JSGO-JSOG joint study. Gynecol Oncol. 2019;153(3):589\u201396.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1684_CR19","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1210\/en.2018-00794","volume":"160","author":"SE Bulun","year":"2019","unstructured":"Bulun SE, Wan Y, Matei D. Epithelial mutations in endometriosis: link to ovarian cancer. Endocrinology. 2019;160(3):626\u201338.","journal-title":"Endocrinology"},{"issue":"9","key":"1684_CR20","first-page":"924","volume":"5","author":"T Terada","year":"2012","unstructured":"Terada T. Endometrioid adenocarcinoma of the ovary arising in atypical endometriosis. Int J Clin Exp Pathol. 2012;5(9):924\u20137.","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"1684_CR21","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","volume":"34","author":"CG Przybycin","year":"2010","unstructured":"Przybycin CG, Kurman RJ, Ronnett BM, Shih Ie M, Vang R. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol. 2010;34(10):1407\u201316.","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"1684_CR22","first-page":"850","volume":"29","author":"M Yasuda","year":"2011","unstructured":"Yasuda M, Kato T, Suzuki H. Topics in ovarian tumors: ovarian tumors and immunohistochemistry. Pathol Clin Med. 2011;29(8):850\u20135.","journal-title":"Pathol Clin Med"},{"issue":"2","key":"1684_CR23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jcp.2007.049478","volume":"61","author":"WG McCluggage","year":"2008","unstructured":"McCluggage WG. My approach to and thoughts on the typing of ovarian carcinomas. J Clin Pathol. 2008;61(2):152\u201363.","journal-title":"J Clin Pathol"},{"issue":"1 Suppl 1","key":"1684_CR24","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1097\/PGP.0000000000000488","volume":"38","author":"M Kobel","year":"2019","unstructured":"Kobel M, Ronnett BM, Singh N, Soslow RA, Gilks CB, McCluggage WG. Interpretation of P53 immunohistochemistry in endometrial carcinomas: toward increased reproducibility. Int J Gynecol Pathol. 2019;38(1 Suppl 1):S123\u201331.","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"1684_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/modpathol.2014.61","volume":"28","author":"Y Yamashita","year":"2015","unstructured":"Yamashita Y, Nagasaka T, Naiki-Ito A, Sato S, Suzuki S, Toyokuni S, et al. Napsin A is a specific marker for ovarian clear cell adenocarcinoma. Mod Pathol. 2015;28(1):111\u20137.","journal-title":"Mod Pathol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-01684-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-022-01684-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-01684-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T11:12:58Z","timestamp":1649157178000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-022-01684-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1684"],"URL":"https:\/\/doi.org\/10.1186\/s12905-022-01684-3","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,5]]},"assertion":[{"value":"20 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was exempt from review by the Institutional Review Board of Fukushima Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and all accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflict of interest to declare or competing financial interests regarding this report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}